A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer

Clinical trial NCT04889495 · WITHDRAWN

Trial details

NCT number: NCT04889495
Sponsor: Pfizer
Status: WITHDRAWN
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer Metastatic Colorectal Cancer Metastatic Breast Cancer Metastatic Kidney Cancer Cervical Cancer Epithelial Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer

Start date: 2025-05-16
Primary completion: 2025-08-16
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.